Cleared Traditional

K854673 - DSL ANDROSTENEDIONE RIA (DSL # 4200)

K854673 is the FDA 510(k) clearance for DSL ANDROSTENEDIONE RIA (DSL # 4200) by Diagnostic Systems Laboratories, Inc.. It is a Class 1 Chemistry device (product code CIZ) cleared through the Traditional 510(k) pathway after a 62-day FDA review.

K854673 · Diagnostic Systems Laboratories, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1986
Decision
62d
Days
Class 1
Risk

K854673 is an FDA 510(k) clearance for the DSL ANDROSTENEDIONE RIA (DSL # 4200). Classified as Radioimmunoassay, Androstenedione (product code CIZ), Class I - General Controls.

Submitted by Diagnostic Systems Laboratories, Inc. (Webster, US). The FDA issued a Cleared decision on January 22, 1986 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1075 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Diagnostic Systems Laboratories, Inc. devices

Submission Details

510(k) Number K854673 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 21, 1985
Decision Date January 22, 1986
Days to Decision 62 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
26d faster than avg
Panel avg: 88d · This submission: 62d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code CIZ Radioimmunoassay, Androstenedione
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1075
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - CIZ Radioimmunoassay, Androstenedione

Devices cleared under the same product code (CIZ) and FDA review panel - the closest regulatory comparables to K854673.
ACTIVE ANDROSTENEDIONE EIA
K963002 · Diagnostic Systems Laboratories, Inc. · Aug 1996
COAT-A-COUNT DIRECT ANDROSTENEDIONE
K954755 · Diagnostic Products Corp. · Nov 1995
ACTIVE ANDROSTANEDIOL GLUCURONIDE
K934751 · Diagnostic Systems Laboratories, Inc. · Jan 1994
DSL ACTIVE ANDROSTENEDIONE RIA (DSL #3800)
K854650 · Diagnostic Systems Laboratories, Inc. · Dec 1985
COAT-A-COUNT ANDROSTENEDIONE RIA KIT
K844398 · Diagnostic Products Corp. · Dec 1984